UC Siemens Center presents at IFEES Webinar

The University of Cincinnati's Siemens Simulation Technology Center gave a presentation to engineers from around the world during a webinar sponsored by the International Federation of Engineering Education Societies.

UC simulation center directors Sam Anand and Jay Kim, both Ph.D., presented on integration of Siemens simulation apps within the engineering curriculum. 

The International Federation of Engineering Education Societies offers webinars for engineering educators and stakeholders. These global webinars are attended by individuals from academia and industry. Many cutting-edge and controversial topics in engineering and engineering pedagogy are discussed in these webinars.

The webinar began with Gil Morris, project manager at Siemens Digital Industries Software, introducing the center and its directors. Anand highlighted the curriculum integration and industry outreach for digital manufacturing and additive manufacturing at the center.

He shared the various tools developed at the center that are integrated with Siemens NX software.

Kim continued by highlighting the vertical integration of courses with simulation software in the curriculum for both undergraduate and graduate students. He expressed the need to nurture engineers with strong fundamental knowledge and simulation technology. 

About 440 people around the world attended the webinar.

(Check out the entire webinar in the IFEES library.)

This image shows the lap simulation of Formula SAE car using Amesim. Here the view is from the driver's seat.  The steering wheel and track is visible in this view from the FSAE car.

A slide from a UC presentation demonstrations an engineering application using a Formula SAE car simulation. Graphic/Provided

Related Stories

2

Researchers work to uncover new information on long-term use of...

November 5, 2024

A new chapter in obesity care has emerged. In addition to recently approved medications used for weight management — the GLP-1 receptor agonists — several additional pharmacotherapies are in the works. Yet details on the impact of long-term use are still being uncovered.

Debug Query for this